* Neuronetics Inc STIM.OQ STIM.O is expected to show a
rise in
quarterly revenue when it reports results on March 7.
* The Malvern Pennsylvania-based company is expected to
report a
12.0% increase in revenue to $16.819 million from $15.02 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. The company's guidance on November 8
2022, for the period ended December 31, was for revenue between
$16.00 million and $17.00 million.
* Refinitiv's mean analyst estimate for Neuronetics Inc is
for a
loss of 38 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Neuronetics
Inc
is $9, above its last closing price of $5.22.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.42 -0.42 -0.28 Beat 33.5
Jun. 30 2022 -0.41 -0.41 -0.39 Beat 5.3
Mar. 31 2022 -0.40 -0.40 -0.41 Missed -2.6
Dec. 31 2021 -0.31 -0.32 -0.29 Beat 8.2
Sep. -0.32 -0.30 -0.31 Missed -2.6
30 2021
Jun. 30 2021 -0.24 -0.24 -0.29 Missed -20.8
Mar. 31 2021 -0.29 -0.31 -0.31 Met 0
Dec. 31 2020 -0.23 -0.24 -0.19 Beat 21.1
This summary was machine generated March 3 at 14:46 GMT. All
figures in US dollars unless otherwise stated